The prodrug uses the enzymatic action of FAP to kill FAP+ cells, a mechanism more often used in tumor therapy to help the drug unlock its target more precisely and avoid damage to normal tissue from non-specific cytotoxic drugs (195). This evidence concerns the gene FAP and neoplasm.